Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
European Thyroid Journal · 24.02.2023 · 12 (2)
DOI: 10.1530/etj-22-0226 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, erschienen am 24.02.2023. Verfasst von Meihua Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Repub…. Hauptthemen laut MEDLINE: Graves Disease, Thyroid Neoplasms, Hyperthyroidism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study evaluated the efficacy of antithyroid drugs (ATDs) and risk factors associated with the recurrence of Graves’ hyperthyroidism using a comprehensive retrospective cohort.
Methods
We included 1829 patients newly diagnosed with Graves’ hyperthyroidism, with sufficient follow-up data. Clinical outcomes of the patients and risk factors associated with recurrence-free survival, including the changes in thyrotropin receptor antibody, were evaluated.
Results
The median age of the patients was 44.5 years, and 69% were female. Among the patients, 1235 had a chance to withdraw ATD after a median of 23 (interquartile range (IQR) 17.0–35.5) months of treatment. The first remission rate was 55.6% during a median of 72.7 months of follow-up. After the first recurrence, 95% of patients underwent the second course of ATD treatment for a median of 21.1 (IQR 14.8–31.7) months, and the remission rate was 54.1%. During a median of 67 months of follow-up, 7.7% of patients underwent surgery, and 10.5% underwent radioactive iodine therapy. Approximately 30% were still on ATD therapy for recurrent disease or prolonged low-dose maintenance. Younger age (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine and School of Medicine, Seoul, Republic of Korea.
- Division of Endocrinology and Metabolism, Department Internal Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea.
ORCID-Profile: Meihua Jin, Won Gu Kim
Zitieren
APA
Jin, M., Jang, A., Kim, C. A., Kim, T. Y., Kim, W. B., Shong, Y. K., Jeon, M. J., & Kim, W. G. (2023). Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort. European Thyroid Journal, 12(2). https://doi.org/10.1530/etj-22-0226
Vancouver
Jin M, Jang A, Kim CA, Kim TY, Kim WB, Shong YK, et al. Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort. European Thyroid Journal. 2023;12(2). doi:10.1530/etj-22-0226
BibTeX
@article{Jin2023,
author = {Jin, Meihua and Jang, Ahreum and Kim, Chae A and Kim, Tae Yong and Kim, Won Bae and Shong, Young Kee and Jeon, Min Ji and Kim, Won Gu},
title = {Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort},
journal = {European Thyroid Journal},
year = {2023},
volume = {12},
number = {2},
doi = {10.1530/etj-22-0226}
}
EUVIMED